TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Teva Pharmaceutical Industries Ltd quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Teva Pharmaceutical Industries Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $3.01B, a 2.05% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $3.01B -$63M -2.05% Dec 31, 2023 10-K 2024-02-12
Q4 2022 $3.07B +$349M +12.8% Dec 31, 2022 10-K 2024-02-12
Q4 2021 $2.72B +$176M +6.91% Dec 31, 2021 10-K 2023-02-10
Q4 2020 $2.55B +$573M +29% Dec 31, 2020 10-K 2022-02-09
Q4 2019 $1.97B Dec 31, 2019 10-K 2021-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.